Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 54

Results For "laboratories"

859 News Found

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
News | May 03, 2023

CPHI & PMEC China 2023 to see surge from pent up international ingredients demand

China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey


Evonik starts construction of new U.S. facility for pharmaceutical lipids
News | April 29, 2023

Evonik starts construction of new U.S. facility for pharmaceutical lipids

Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness


Siegfried breaks ground on new R&D center for drug substances in Switzerland
News | April 26, 2023

Siegfried breaks ground on new R&D center for drug substances in Switzerland

The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth


Xyall and Indica Labs forge collaboration to transform precision oncology workflows
News | April 25, 2023

Xyall and Indica Labs forge collaboration to transform precision oncology workflows

Bridging the gap between histopathology and molecular pathology


Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr
News | April 25, 2023

Ipca to acquire 33.4% stake in Unichem Labs for Rs 1,034 Cr

The business and product range of Ipca and that of Unichem complements each others business and product range


Sai Life Sciences opens research facility SSRL
News | April 22, 2023

Sai Life Sciences opens research facility SSRL

Fully equipped labs with 75-member team set-up and made operational in <100 days


Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices
Clinical Trials | April 17, 2023

Molbio Diagnostics and SigTuple join hands to build next-gen diagnostic testing devices

The blood test market worldwide is today around $75-80 billion


Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline
News | April 17, 2023

Merck acquires Prometheus Biosciences for US$10.8 billion to strengthen immunology pipeline

Prometheus Biosciences’ comprehensive data set enables target discovery and precision medicine approach in inflammation and immunology


Moderna and Merck announce an investigational individualized neoantigen therapy
Clinical Trials | April 17, 2023

Moderna and Merck announce an investigational individualized neoantigen therapy

mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients


Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology
Clinical Trials | April 15, 2023

Alpenglow Biosciences and Mayo Clinic collaborate to advance pathology and drug development through 3D spatial biology

Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging